Logo

American Heart Association

  2
  0


Final ID: LBP21

Acellular Tissue Engineered Vessels as Conduits for Coronary Artery Bypass Grafting

Abstract Body (Do not enter title and authors here): Introduction: Vascular conduit for coronary artery bypass grafting (CABG) can be limited due to the availability and quality of autologous vein. A readily-available and biological conduit having good durability, patency, and biocompatibility would fill an important unmet need in CABG surgery. Here we evaluated the function and host remodeling of a small diameter Acellular Tissue Engineered Vessel (sdATEV) in a large primate model of CABG.
Methods: ATEVs comprised of human vascular extracellular matrix proteins, with an inner diameter of 3.5 mm and length of 20 cm, were grown and decellularized using a biomanufacturing platform. Five adult baboons (age 6-10 years, 33.0 ± 2.5 kg) underwent CABG from the aorta to the right coronary artery (RCA), and were followed for 6 months. Conduit blood flow and pulsatility index (PI) were measured at implant and explant while patency and cardiac function was assessed at 1, 3, and 6 months using computed tomography angiography (CTA). Immunohistochemistry and high-definition spatial transcriptomics were performed to characterize host recellularization and remodeling of the sdATEVs.
Results: All sdATEV CABG conduits remained patent with no evidence of dilatation, stenosis, or mechanical failure. Conduit blood flow was 32.4 ± 10.3 mL/min (PI: 1.7 ± 0.9) at implant and 34.8 ± 13.5 mL/min (PI: 1.2 ± 0.0) at explant. Luminal diameter of the sdATEV remodeled from 3.5 mm at implant to 2.3 ± 0.5 mm distally at 6 months, more similar to the 1.7 mm diameter of the RCA. Explant histology identified pannus ingrowth from native arteries as the mechanism for the progressive size matching of the sdATEV. At 6 months, pannus smooth muscle cells were mostly quiescent (Ki67-), which correlated with low localized TGFβ1 expression, and high endothelial nitric oxide synthase and prostacyclin synthase expression from adjacent luminal endothelial cells. In addition, the sdATEV wall was repopulated with cells expressing smooth muscle cell markers and surrounded by a neoadventitia containing capillaries lined with CD31+/vWF+ endothelial cells.
Conclusion: The sdATEV is an off-the-shelf conduit that exhibited both robust mechanical performance and adaptive host remodeling in a baboon CABG model.
  • Nash, Kevin  ( Humacyte Global, Inc. , Durham , North Carolina , United States )
  • Prichard, Heather  ( Humacyte Global, Inc. , Durham , North Carolina , United States )
  • Niklason, Laura  ( Humacyte Global, Inc. , Durham , North Carolina , United States )
  • Kypson, Alan  ( UNC Rex Cardiac Surgical Specialist , Raleigh , North Carolina , United States )
  • Williams, Adam  ( Duke University , Durham , North Carolina , United States )
  • Benkert, Abigail  ( Duke University , Durham , North Carolina , United States )
  • Daubert, Melissa  ( Duke University , Durham , North Carolina , United States )
  • Kirkton, Robert  ( Humacyte Global, Inc. , Durham , North Carolina , United States )
  • Levitan, Garyn  ( Humacyte Global, Inc. , Durham , North Carolina , United States )
  • Mccartney, Sharon  ( Duke University , Durham , North Carolina , United States )
  • Mehta, Sachin  ( Duke University , Durham , North Carolina , United States )
  • Naegeli, Kaleb  ( Humacyte Global, Inc. , Durham , North Carolina , United States )
  • Author Disclosures:
    Kevin Nash: No Answer | Heather Prichard: DO have relevant financial relationships ; Employee:Humacyte:Active (exists now) | Laura Niklason: No Answer | Alan Kypson: DO have relevant financial relationships ; Consultant:Humacyte:Active (exists now) ; Speaker:Medtronic:Past (completed) | Adam Williams: No Answer | Abigail Benkert: No Answer | Melissa Daubert: DO NOT have relevant financial relationships | Robert Kirkton: DO have relevant financial relationships ; Employee:Humacyte Global, Inc.:Active (exists now) | Garyn Levitan: DO NOT have relevant financial relationships | Sharon McCartney: DO have relevant financial relationships ; Consultant:Humacyte Inc:Active (exists now) | Sachin Mehta: DO have relevant financial relationships ; Consultant:Humacyte:Active (exists now) | Kaleb Naegeli: DO have relevant financial relationships ; Employee:Humacyte Global, Inc:Active (exists now) ; Individual Stocks/Stock Options:Humacyte Global, Inc:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Late-Breaking Basic Science: New Insights in Cardiovascular Health and Disease

Saturday, 11/16/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
Development of SA Node Organoids: A Multicellular Approach to Biological Pacemaking

Won Jihee, Son Young Hoon, Cho Hee Cheol, Park Sung

Cellularized Tissue-Engineered Biological Ventricular Assist Devices Improve Global Cardiac Function in a Porcine Model of Ischemic Cardiomyopathy

Wu Ming, Gillijns Hilde, Holemans Patricia, Ginkels Mieke, Dokter Inge, Jungst Tomasz, Sluijter Joost, Groll Jürgen, Mazo Vega Manuel, Serra Margarida, Prosper Felipe, Oosterlinck Wouter, Janssens Stefan, Vincente Pedro, Claus Piet, Algoet Michiel, Braig Johannes, Van Mil Alain, Iglesias Garcia Olalla, Del Pilar Montero Calle Maria

More abstracts from these authors:
Predicting Downstream Aneurysmal Degeneration Following Type A Dissection Repair With Computational Fluid Dynamics

Jensen Christopher, Ghorbannia Arash, Urick David, Moya-mendez Mary, Vekstein Andrew, Draeger Erik, Williams Adam, Hughes G, Randles Amanda

Reassessing Thresholds for Pulmonary Hypertension in Healthy and Early Stage Heart Failure - Project Baseline Health Study

Alenezi Fawaz, Daubert Melissa, Haddad Francois, Celestin Bettia, Santana Everton, Bagherzadeh Shadi, Alajmi Hasan, Salerno Michael, Shah Svati, Rajagopal Sudarshan, Douglas Pamela

You have to be authorized to contact abstract author. Please, Login
Not Available